Pembrolizumab
Pharmac won't be swayed on melanoma drug
12 Feb 2016
Pharmac is refusing to be rushed into funding a hotly debated new drug for advanced melanoma.
RNZ
Pharmac is refusing to be rushed into funding a hotly debated new drug for advanced melanoma.